Unlocking The Potential of NSF (DEE96) as A Drug Target Or Biomarker
Unlocking The Potential of NSF (DEE96) as A Drug Target Or Biomarker
The National Science Foundation (NSF) is a non-profit organization that supports scientific research and discovery in the United States. The NSF has a long history of funding research in a wide range of fields, including biology and medicine. One area in which the NSF has made significant investments is in the development of new drugs and other therapeutic compounds. In this article, we will focus on one such drug target, known as NSF (DEE96), and its potential as a drug or biomarker.
NSF (DEE96) is a protein that is expressed in many different tissues throughout the body, including the brain, spinal cord, and peripheral tissues. It is a key regulator of the nervous system, and is involved in the development and maintenance of neural circuits. Studies have shown that NSF (DEE96) plays a critical role in the regulation of neural plasticity, which is the ability of the nervous system to change and adapt in response to new experiences or environments.
One of the key challenges in studying NSF (DEE96) is its complex structure. The protein is composed of multiple domains, including an extracellular domain that is involved in cell signaling, a transmembrane domain that spans the cell membrane, and an intracellular domain that is involved in protein-protein interactions. The precise function of each of these domains is not well understood, and much of the research on NSF (DEE96) has focused on understanding its structure and mechanism.
In recent years, researchers have made significant progress in the study of NSF (DEE96). One of the main focuses of research has been on the regulation of neural plasticity by NSF (DEE96). Studies have shown that NSF (DEE96) plays a critical role in the regulation of neurogenesis, which is the process by which new neurons are generated in the brain. This is important for understanding how the brain learns and adapts to new experiences or environments.
Another area of research has been the study of NSF (DEE96)'s role in the regulation of synaptic plasticity, which is the ability of the connections between neurons to change and adapt in response to new experiences or environments. Studies have shown that NSF (DEE96) plays a critical role in the regulation of synaptic plasticity, and that it is involved in the formation of new synapses and the modification of existing ones.
In addition to its role in neural plasticity, NSF (DEE96) is also of interest as a potential drug target or biomarker. The NSF is a key regulator of many different processes in the body, and studies have shown that it is involved in the regulation of a wide range of physiological processes, including inflammation, stress, and cell signaling. This makes it an attractive target for the development of new drugs or diagnostic tools.
One of the key challenges in studying NSF (DEE96) as a potential drug target is its complex structure and function. The exact mechanism by which NSF (DEE96) interacts with other molecules is not well understood, and much of the research on its potential as a drug target has focused on understanding its structure and mechanism.
In recent years, researchers have made significant progress in the study of NSF (DEE96) as a potential drug target. One of the main focuses of research has been on understanding the regulation of NSF (DEE96) by other molecules, including drugs or other signaling molecules. Studies have shown that NSF (DEE96) is involved in the regulation of a wide range of physiological processes, including inflammation, stress, and cell signaling. This makes it an attractive target for the development of new drugs or diagnostic tools.
Another area of research has been the study of NSF (DEE96)'s role in the regulation of neural plasticity,
Protein Name: N-ethylmaleimide Sensitive Factor, Vesicle Fusing ATPase
Functions: Required for vesicle-mediated transport. Catalyzes the fusion of transport vesicles within the Golgi cisternae. Is also required for transport from the endoplasmic reticulum to the Golgi stack. Seems to function as a fusion protein required for the delivery of cargo proteins to all compartments of the Golgi stack independent of vesicle origin. Interaction with AMPAR subunit GRIA2 leads to influence GRIA2 membrane cycling (By similarity)
More Common Targets
NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF | NSMCE1 | NSMCE1-DT | NSMCE2 | NSMCE3 | NSMCE4A | NSMF | NSRP1 | NSUN2 | NSUN3 | NSUN4 | NSUN5 | NSUN5P1 | NSUN5P2 | NSUN6 | NSUN7 | NT5C | NT5C1A | NT5C1B | NT5C1B-RDH14 | NT5C2 | NT5C3A | NT5C3AP1 | NT5C3B | NT5CP2 | NT5DC1 | NT5DC2 | NT5DC3 | NT5DC4 | NT5E | NT5M | NTAN1 | NTAQ1 | NTF3 | NTF4 | NTHL1 | NTM | NTMT1 | NTMT2 | NTN1 | NTN3 | NTN4 | NTN5 | NTNG1 | NTNG2 | NTPCR | NTRK1 | NTRK2 | NTRK3 | NTRK3-AS1 | NTS | NTSR1 | NTSR2 | NuA4 histone acetyltransferase (HAT) complex | NUAK Family SNF1-like Kinase (nonspcified subtype) | NUAK1 | NUAK2 | NUB1 | NUBP1 | NUBP2 | NUBPL | NUCB1 | NUCB2 | NUCKS1 | Nuclear factor interleukin-3-regulated protein-like | Nuclear factor of activated T-cells | Nuclear Pore Complex | Nuclear Receptor ROR | Nuclear transcription factor Y | Nucleoside Diphosphate Kinase (NDK) | Nucleosome Remodeling and Deacetylase (NuRD) Complex | Nucleosome-remodeling factor complex (NURF) | NUDC | NUDCD1 | NUDCD2 | NUDCD3 | NUDCP2 | NUDT1 | NUDT10 | NUDT11 | NUDT12 | NUDT13 | NUDT14 | NUDT15 | NUDT15P1 | NUDT16 | NUDT16-DT | NUDT16L1 | NUDT16L2P | NUDT17 | NUDT18 | NUDT19 | NUDT2 | NUDT21